This page shows the latest ThromboGenics news and features for those working in and with pharma, biotech and healthcare.
It is also good news for the drug's original developers ThromboGenics, which sold non-US rights for Jetrea to Novartis in 2012 in a deal worth up to 375m, and ... progressive disease much earlier and as soon as patients start experiencing symptoms
Once launched, Jetrea will be marketed by Novartis' eye division Alcon, which purchased non-US rights to the drug from Belgian pharma company ThromboGenics in March 2012. ... ThromboGenics retains the rights to commercialise the drug in the US, where it
It purchased the rights to commercialise Jetrea outside the US from its developers ThromboGenics in 2012 as part of a deal potentially worth up to 375m.
The availability of the drug is a major boon for VMA patients, who until now have only had surgery as a treatment option, according to ThromboGenics. ... Jetrea was approved for symptomatic VMA last year in the US, where ThromboGenics has retained
Novartis' Alcon division acquired commercialisation rights to Jetrea from its discoverer, the Belgium-based biopharmaceutical company ThromboGenics, in a 375m deal last March.
Chris Buyse (Life Sciences Research Partners and CFO at Thrombogenics) who has been the company's chairman during its successful first phase will step down and Michael Palfreyman will take his
More from news
Approximately 3 fully matching, plus 6 partially matching documents found.
Appoints Susan Schneider as CMO and Vinciane Vangeersdaele as CCO. ThromboGenics has strengthened its senior leadership team with the appointment of Susan Schneider, who joins the Belgian biotech as its chief ... Patrik De Haes, chief executive officer,
He moves from his previous position as non-executive director. Belgium-based biotech ThromboGenics has appointed non-executive director Thomas Clay as its new chairman of the board and succeeds Staf ... Clay has been a non-executive director of
More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...